Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Surgery for macular edema].

C Haritoglou1, A Kampik

  • 1Augenklinik, Ludwig-Maximilians-Universität, München. christos.haritoglou@ak-i.med.uni-muenchen.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|April 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Current treatment strategies for vitreomacular traction and macular holes: a survey of retinal specialists in Germany].

Die Ophthalmologie·2024
Same author

[Tonometry and pachymetry to evaluate fluctuations of intraocular pressure in the context of SCUBA diving].

Die Ophthalmologie·2023
Same author

[Erratum to: Optical coherence tomography biomarkers in epimacular membranes and vitreomacular traction syndrome].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

[Optical coherence tomography biomarkers in epimacular membranes and vitreomacular traction syndrome].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

[Biomarkers in full-thickness and lamellar defects of the macula].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

[Erratum to: Macular changes in optic disc pits-Optic disc pit maculopathy (ODP-M). Pathophysiology and possibilities of surgical treatment].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2019
Same journal

["DOG 2020 online" - for the first time in the von Graefe year].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2024
Same journal

[Are organ and co-cultures an alternative to animal models in ophthalmology?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Pediatric corneal opacities : Even small improvements provide lifelong help].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Myxoma of the conjunctiva].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
See all related articles

Macular edema, a condition recognized since the late 1800s, is caused by various factors including vascular and inflammatory diseases. Modern treatments now include surgical interventions and intravitreal injections for improved patient outcomes.

Area of Science:

  • Ophthalmology
  • Retinal Diseases

Context:

  • Macular edema has been a recognized pathological condition since the late 19th century.
  • Its etiology encompasses vascular, inflammatory, degenerative, congenital diseases, and trauma.

Purpose:

  • To review the evolving therapeutic strategies for macular edema.
  • To highlight recent advancements in treatment modalities.

Summary:

  • Therapeutic approaches have advanced with increased understanding of underlying causes.
  • Current treatments include laser therapy, surgical interventions like pars plana vitrectomy with ILM peeling for vitreoretinal interface abnormalities.
  • Intravitreal triamcinolone is an option for chronic macular edema.

Impact:

Related Experiment Videos

  • Improved management of macular edema through targeted therapies.
  • Enhanced visual outcomes for patients with complex retinal conditions.